Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Clinical trial NCT01292655 · COMPLETED
Trial details
- NCT number
- NCT01292655
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-03
- Primary completion
- 2017-06-22
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.